Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin XL 80mg vs IR 40mg BID in Chinese Patients with Dyslipidemia
NCT01551173Phase 4Completed
- Sponsor
- Novartis
- Start
- Jan 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluvastatin in hypercholesterolemia, mixed dyslipidemia, sponsored by Novartis. Started Jan 2012; status: completed.
02
Drugs
fluvastatin
03
Conditions
hypercholesterolemiamixed dyslipidemia
Beyond the preview
Go deeper on NCT01551173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01551173.